According to the settlement agreement, Genevant Sciences, a subsidiary of Roivant Sciences Ltd., will grant Moderna, Inc. a non-exclusive license allowing the use of its lipid nanoparticle delivery technology for applications in the field of infectious diseases.

老虎证券2026/03/03 21:43

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

EUR/GBP Price Forecast: Rejection at 0.8500 leaves yearly low at 0.8455 exposed

FXStreet•2026/10/07 07:54

Dalio issues another warning: AI is a “classic bubble,” and the tipping point of the bubble is “very close.”

Dalio warns that artificial intelligence is in a "classic bubble," as rising interest rates combined with liquidity demands are pushing it close to the breaking point; he states, "We are already very close to that point."

智通财经•2026/10/07 07:43

A cryptocurrency exchange is considering launching tokenized stocks.

AiCoin•2026/10/07 07:37

A chart: Overview of "pivot points + long and short positions signals" for gold, crude oil, forex, and stock indices on October 7, 2026

汇通财经•2026/10/07 07:35